{"id":1239375,"title":"DSEN Abstract: Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T19:28:35.255000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53927.html?wbdisable=true","snippet":"DSEN Abstract Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Our findings suggest that many patients received valsartan products with nitrosamine…","rawSnapshotUrl":"/api/snapshots/raw/1239375","browseUrl":"https://replay.healtharchive.ca/job-8/20260306192835/https://cihr-irsc.gc.ca/e/53927.html?wbdisable=true#ha_snapshot=1239375","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}